147 related articles for article (PubMed ID: 26438136)
1. Association between COX-2 gene polymorphisms and risk of hepatocellular carcinoma development: a meta-analysis.
Lu SC; Zhong JH; Tan JT; Tang HL; Liu XG; Xiang BD; Li LQ; Peng T
BMJ Open; 2015 Oct; 5(10):e008263. PubMed ID: 26438136
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies.
Xu W; Huang Y; Zhang T; Zhao L; Fan J; Li L
J Cancer Res Ther; 2018; 14(Supplement):S105-S113. PubMed ID: 29578159
[TBL] [Abstract][Full Text] [Related]
3. Associations between Cox-2 rs20417 and rs5275 polymorphisms and the risk of hepatocellular carcinoma: a meta analysis.
Wu H; Wu X; Wan G; Zhang S
Int J Clin Exp Pathol; 2014; 7(10):6898-905. PubMed ID: 25400773
[TBL] [Abstract][Full Text] [Related]
4. Association of cyclooxygenase 2 single-nucleotide polymorphisms and hepatocellular carcinoma in Taiwan.
Chang WS; Yang MD; Tsai CW; Cheng LH; Jeng LB; Lo WC; Lin CH; Huang CY; Bau DT
Chin J Physiol; 2012 Feb; 55(1):1-7. PubMed ID: 22242948
[TBL] [Abstract][Full Text] [Related]
5. The association between three cyclooxygenase-2 polymorphisms and hepatocellular carcinoma risk: a meta-analysis.
Chen Z; Zhu J; Huang C; Lian F; Wu G; Zhao Y
PLoS One; 2015; 10(3):e0118251. PubMed ID: 25730260
[TBL] [Abstract][Full Text] [Related]
6. The association between cyclooxygenase-2 1195 G/A polymorphism and hepatocellular carcinoma: evidence from a meta-analysis.
Bu X; Zhao C
Tumour Biol; 2013 Jun; 34(3):1479-84. PubMed ID: 23494177
[TBL] [Abstract][Full Text] [Related]
7. COX-2 polymorphisms -765G→C and -1195A→G and hepatocellular carcinoma risk.
Gharib AF; Karam RA; Abd El Rahman TM; Elsawy WH
Gene; 2014 Jun; 543(2):234-6. PubMed ID: 24720952
[TBL] [Abstract][Full Text] [Related]
8. Association between COX-2 -1195G>A polymorphism and gastrointestinal cancer risk: A meta-analysis.
Zhang XW; Li J; Jiang YX; Chen YX
World J Gastroenterol; 2017 Mar; 23(12):2234-2245. PubMed ID: 28405152
[TBL] [Abstract][Full Text] [Related]
9. Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.
Jiang G; Yu K; Shao L; Yu X; Hu C; Qian P; Xie H; Li J; Zheng J; Zheng S
BMC Cancer; 2015 Apr; 15():314. PubMed ID: 25927412
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of tumor necrosis factor-alpha and hepatocellular carcinoma risk: a HuGE systematic review and meta-analysis.
Wei Y; Liu F; Li B; Chen X; Ma Y; Yan L; Wen T; Xu M; Wang W; Yang J
Dig Dis Sci; 2011 Aug; 56(8):2227-36. PubMed ID: 21336601
[TBL] [Abstract][Full Text] [Related]
11. Potentially functional COX-2-1195G>A polymorphism increases the risk of digestive system cancers: a meta-analysis.
Dong J; Dai J; Zhang M; Hu Z; Shen H
J Gastroenterol Hepatol; 2010 Jun; 25(6):1042-50. PubMed ID: 20594217
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 promoter polymorphism -899G/C is associated with hepatitis B-related liver cancer in a Chinese population of Gansu province.
He JH; Li YM; Zhang QB; Ren ZJ; Li X; Zhou WC; Zhang H; Meng WB; He WT
Chin Med J (Engl); 2011 Dec; 124(24):4193-7. PubMed ID: 22340386
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of the CYP1B1 gene and hepatocellular carcinoma risk in a Chinese population.
Liu F; Luo LM; Wei YG; Li B; Wang WT; Wen TF; Yang JY; Xu MQ; Yan LN
Gene; 2015 Jun; 564(1):14-20. PubMed ID: 25796598
[TBL] [Abstract][Full Text] [Related]
14. Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma.
Akkız H; Bayram S; Bekar A; Akgöllü E; Ülger Y
Mol Cell Biochem; 2011 Jan; 347(1-2):201-8. PubMed ID: 21042835
[TBL] [Abstract][Full Text] [Related]
15. Associations between hepatocellular carcinoma risk and rs3212227 and rs568408 polymorphisms: a systematic review and meta-analysis.
Kong C; Chen M; Fan X; Chen X
J Int Med Res; 2020 Aug; 48(8):300060520943420. PubMed ID: 32809897
[TBL] [Abstract][Full Text] [Related]
16. Association between the HSPA1B ±1267A/G polymorphism and cancer risk: a meta-analysis of 14 case-control studies.
Kuang D; Chen W; Song YZ; Yu YY; Zhang DY; Wu L; Tang J
Asian Pac J Cancer Prev; 2014; 15(16):6855-61. PubMed ID: 25169537
[TBL] [Abstract][Full Text] [Related]
17. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
18. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis.
Xu Y; Li L; Xiang X; Wang H; Cai W; Xie J; Han Y; Bao S; Xie Q
Gene; 2013 Sep; 527(2):584-93. PubMed ID: 23791656
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan.
Su CH; Hsiao CL; Chang WS; Liu LC; Wang HC; Tsai CW; Li LY; Tsai CH; Bau DT
Anticancer Res; 2014 Nov; 34(11):6711-6. PubMed ID: 25368279
[TBL] [Abstract][Full Text] [Related]
20. Association of intercellular adhesion molecule-1 single nucleotide polymorphisms with hepatocellular carcinoma susceptibility and clinicopathologic development.
Chen TP; Lee HL; Huang YH; Hsieh MJ; Chiang WL; Kuo WH; Chou MC; Yang SF; Yeh CB
Tumour Biol; 2016 Feb; 37(2):2067-74. PubMed ID: 26341495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
